Europe loses 171,000 hospital beds in decade
According to Eurostat, the decrease is partly attributed to a shift in healthcare strategies, including shorter hospital stays and a growing reliance on outpatient services.
The data highlights disparities among countries. Bulgaria and Germany recorded the highest ratios, with 823 and 766 hospital beds per 100,000 inhabitants, respectively. In contrast, Sweden and Denmark had the lowest, with 190 and 248 beds per 100,000 people, due to their focus on strengthening primary healthcare. Meanwhile, the Netherlands and Sweden lead the EU in long-term care bed availability.
While this transformation reflects progress in service delivery, health experts caution that the overall reduction in hospital beds could pose risks, particularly in the event of future health emergencies or crises.
Follow Emirates 24|7 on Google News.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
11 hours ago
- Zawya
Kingdom Health signals launch of second phase with JOD 125mln development agreement
Amman, Jordan – Kingdom Health has announced the launch of its second phase of development, marking a significant milestone as the first phase of core construction concludes. The announcement was made during a ceremony held on Thursday, 10 July, at the St. Regis hotel in Amman, where a JOD 125 million agreement was signed between the Kingdom Health and MID Contracting Company. Under this agreement, the contracting company will undertake architectural finishing, interior fit-out, and the installation of electro-mechanical systems for the project's medical and academic facilities. These efforts pave the way for the trial phase, during which vital systems, equipment and operational infrastructure will begin to be integrated. The signing ceremony was attended by Prof. Feras Hawari, Minister of Health; Dr. Azmi Mahafza, Minister of Education and Minister of Higher Education and Scientific Research; Zaher Al-Qatarneh, Secretary General of the Ministry of Investment and Acting General Manager of the Jordan Investment Fund; and Mohammed bin Hassan Mounis, the Acting Charge d'Affaires of the Embassy of the Kingdom of Saudi Arabia in the Hashemite Kingdom of Jordan. They were joined by senior dignitaries, officials from relevant government entities, local and international partners, and representatives from both parties. Commenting on the agreement, Fadi Al-Said, Chairman at the Kingdom Health, stated, 'We are proud of the progress achieved in the Kingdom Health project. This is not just an investment in health and educational infrastructure, it is a long-term investment in people and society. Through strategic partnerships and a clear vision, we aim to establish an institutional model that strengthens Jordan's position as a regional hub for healthcare and education.' Dr. Mahmoud Sarhan, CEO of the Kingdom Health, added, 'The second phase marks a strategic shift toward institutional and operational empowerment. It is when our vision becomes tangible, offering a cutting-edge experience aligned with global standards in healthcare and medical education. This will be based on a smart infrastructure and an integrated operational system that includes advanced communications, facility management, and modern medical technologies, all supported by our global academic and medical partnerships.' Chairman of the Board at MID Contracting Company, Eng. Ala' Al-Masri, further commented, 'We are honored to collaborate on this landmark project, one of pioneering initiatives in Jordan and the region. Being entrusted with responsibilities to deliver on architectural finishing, interior outfitting, and the installation of electro-mechanical systems that require high precision and engineering integration demonstrates the strong faith in the excellence of our services. We are committed to applying best engineering and operational practices to ensure the facilities meet the highest standards of quality, intelligent operation, and safety, enabling the project to fulfill its institutional vision effectively and sustainably.' The Kingdom Health serves as a transformative model in the healthcare and medical education sectors. It reflects the convergence of Jordan's national vision and high-impact investments supported by the Saudi Jordanian Investment Company, a wholly owned subsidiary of PIF. The project is being implemented through a public-private partnership under a build-operate-transfer (BOT) framework, ensuring sustainable investment and a meaningful social and economic impact. Construction is progressing steadily, with full operations expected by the end of 2027. The project spans a built-up area of over 128,000 square meters. Upon its operational phase, it will include the Kingdom University for Medical Sciences with a capacity of 600 seats and state-of-the-art educational facilities. These will integrate modern medical curricula with artificial intelligence and clinical training to graduate a new generation of doctors, researchers, and leaders in healthcare and medical education. Additionally, the project includes a 330-bed university hospital, 72 outpatient clinics, a specialized children's hospital, and five centers of excellence that will directly address major health challenges in Jordan and the region. The project is distinguished by world-class partnerships, notably with University College London (UCL) Medical School as the academic partner and UCLA Health as the medical partner. Beyond its academic and medical impact, the project is expected to generate more than 5,000 direct and indirect job opportunities, with potential for future expansion. It represents a transformative investment in Jordan's future, serving as a driver of economic growth, a catalyst for scientific research, and a destination for medical tourism, in alignment with His Majesty King Abdullah II's vision of establishing Jordan as a regional center of excellence in medical and health education.
Khaleej Times
13 hours ago
- Khaleej Times
Dr Azad Moopen ranks among India's top 5 cash-rich promoters
Dr. Azad Moopen, founder and chairman of Aster DM Healthcare, has been ranked among India's top five cash-rich promoters in FY25, earning a dividend income of Rs 25.94 billion. He is the only entrepreneur from Kerala on the elite list, alongside industrial heavyweights like Mukesh Ambani, Anil Agarwal, and Azim Premji. Aster DM Healthcare declared a special dividend of Rs118 per share, a final dividend of Rs2 per share, and an interim dividend of Rs 4 per share in FY25. With a 42 per cent promoter stake, the company's financial performance underscores its strong fundamentals and strategic growth. Aster's recent merger with Quality Care India Ltd., backed by Blackstone, has created one of India's top three hospital networks — Aster DM Quality Care Ltd — with 38 hospitals and over 10,300 beds across 27 cities. From a single clinic in Dubai in 1987, Dr. Moopen has built a global network of over 900 facilities and 34,000 employees across seven countries. He also established Kerala's first medical college in a tribal district and founded Aster Volunteers, one of the world's largest medical volunteer networks with over 85,000 members. Honoured with the Padma Shri and Pravasi Bharatiya Samman, Dr. Moopen continues to drive impact-led healthcare expansion. His rise reflects a rare blend of financial acumen and social commitment, proving that sustainable entrepreneurship can create both value and lasting change.
Zawya
2 days ago
- Zawya
Tackling mpox through global and local collaboration in the Democratic Republic of the Congo
Mpox continues to strain the Democratic Republic of the Congo's health system. Between 1 January and 31 May 2025, the country reported more than 12 000 suspected cases and 22 deaths, accounting for over 50% of all mpox cases in Africa this year. In response, World Health Organization (WHO) and the Global Outbreak Alert and Response Network (GOARN) are supporting the country's efforts to strengthen clinical care, improve detection and build the skills and engagement of frontline responders. GOARN, a network coordinated by WHO that supports countries respond to health emergencies by deploying personnel and resources, mobilized seven specialists to support Democratic Republic of the Congo's mpox response. Working both on the ground and remotely from Nairobi, the team provided expertise in treatment, data analysis, epidemiology, and disease surveillance. Among them was Dr Andre Basilua Muzembo, a case management specialist from the University of Hyogo in Japan. Over nearly two months, he worked with health professionals at national level and WHO teams covering logistics, infection prevention, vaccination, and mpox response to ensure effective coordination. At Clinique Kinoise, Kinshasa's main referral centre for severe mpox cases, he provided support to help address critical challenges. The facility, with 42 beds and an average of 20 patients, operated with just around five out of 95 staff trained on mpox management. Chronic shortages of gloves, medicines, and essential equipment, combined with limited access to laboratory testing and difficult working conditions, contributed to a mortality rate of around 10%. During more than 30 visits to five mpox treatment centres across Kinshasa, mainly in Clinique Kinoise, he mentored staff in compassionate care, worked with colleagues to improve hygiene practices and helped coordinate delivery of medicines and medical supplies. He also worked closely with Kokolo, Vijana, Masina Cinquantenaire and Kinkole treatment centres to streamline referrals and maintain continuity of care. The response team placed special attention to high-risk groups, including children, pregnant women, and people living with HIV. Some pregnant patients arrived with foetal deaths, partly due to difficulties in accessing essential diagnostic tools such as ultrasound. In collaboration with the National AIDS Control Programme (PNMLS) and Médecins Sans Frontières (MSF), at least five HIV-Mpox co-infected patients were referred for specialized treatment. When two mpox cases were detected in a Kinshasa orphanage, an emergency vaccination reached 30 people at risk. Alerts on cases of infected prisoners at Kokolo Hospital, followed by more than 30 cases reported at Ndolo prison, underscored the need for sustained outreach in vulnerable settings. As part of efforts to strengthen the health system beyond the immediate response, 59 front-line workers, including 27 doctors and 32 nurses from the Clinique Kinoise received training in clinical management of mpox. Heavy flooding then complicated the outbreak response, requiring a more coordinated and multisectoral efforts. Response teams faced overlapping emergencies—managing mpox and cholera while supporting displaced communities. At four evacuation sites, including Stade Tata Raphaël and Bandalungwa, WHO and partners delivered essential supplies such as medicines, cholera kits, and hygiene items. "Despite extremely difficult working conditions, I witnessed how important it was to work to save lives with determination, compassion and team spirit. Resilience is not just about coping with adversity, it's about living through it with those affected, listening to those on the edge of despair and doing what we can with even the most modest of means," says Dr Muzembo. These deployments are possible thanks to the support of UK public health rapid support team, Public health agency of Canada, Research institute of nursing care for people and community, University of Hyogo, and European centre for disease prevention and control. 'This mission underscores the critical importance of partnership and collaboration in health emergencies,' said Dr Jerry-Jonas Mbasha, GOARN focal point at WHO Regional Office for Africa and WHO operational partnerships officer. 'GOARN is a vital pillar in the Global Health Emergency Corps, ensuring a coordinated health emergency workforce that is both rooted in countries and connected regionally and globally.' 'GOARN brings in targeted expertise to address critical gaps on the ground. With hands-on support and capacity strengthening, we are empowering countries to manage emergencies themselves. While the challenges in DRC remain, our continued mission is to work together, contain the outbreak, and build long-term resilience in the health system,' says Dr Mbasha. As the DRC continues to respond to mpox, joint efforts by national and international partners highlight the importance of collaboration. "This mission has not only helped us respond to the outbreak but also strengthened the local health system in ways that will last well beyond the end of the current crisis," says Dr Boureima Hama Sambo, WHO Representative in the Democratic Republic of the Congo. Distributed by APO Group on behalf of World Health Organization (WHO) - Democratic Republic of Congo.
